| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 4,525 | 5,089 | 2,465 | 1,307 | | Cost of Revenue | 2,804 | 2,991 | 1,356 | 703 | | | Gross Profit | 1,721 | 2,098 | 1,109 | 604 | | | Operating Expenses | | Research Development | 137 | 172 | 172 | 277 | | Selling General and Administrative | 1,174 | 1,239 | 878 | 705 | | Non Recurring |
-
| 120 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 410 | 567 | 59 | (378) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (14) | 1 | 2 | | Earnings Before Interest And Taxes | 358 | 582 | 60 | (376) | | Interest Expense |
-
| 466 |
-
|
-
| | Income Before Tax | 358 | 116 | 60 | (376) | | Income Tax Expense | (21) | 5 |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 380 | 111 | 60 | (376) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 379 | 111 | 60 | (376) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $379 | $111 | $60 | ($376) |
|
0.09% Nasdaq 
0.39%
Income Statement
